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Abstract
Background: Wound infection is a common complication following caesarean section. Factors influencing the risk
of infection may include the suture material for skin closure, and closure of the subcutaneous fascia. We assessed
the effect of skin closure with absorbable versus non-absorbable suture, and closure versus non-closure of the
subcutaneous fascia on risk of wound infection following Caesarean section.
Methods: Women undergoing caesarean birth at an Adelaide maternity hospital were eligible for recruitment to a
randomised trial using a 2 × 2 factorial design. Women were randomised to either closure or non-closure of the
subcutaneous fascia and to subcuticular skin closure with an absorbable or non-absorbable suture.
Participants were randomised to each of the two interventions into one of 4 possible groups: Group 1 - non-
absorbable skin suture and non-closure of the subcutaneous fascia; Group 2 - absorbable skin suture and non-
closure of the subcutaneous fascia; Group 3 - non-absorbable skin suture and closure of the subcutaneous fascia;
and Group 4 - absorbable skin suture and closure of the subcutaneous fascia.
The primary outcomes were reported wound infection and wound haematoma or seroma within the first 30 days
after birth.
Results: A total of 851 women were recruited and randomised, with 849 women included in the analyses (Group 1:
216 women; Group 2: 212 women; Group 3: 212 women; Group 4: 211 women).
In women who underwent fascia closure, there was a statistically significant increase in risk of wound infection
within 30 days post-operatively for those who had skin closure with an absorbable suture (Group 4), compared with
women who had skin closure with a non-absorbable suture (Group 3) (adjusted RR 2.17; 95% CI 1.05, 4.45; p =
0.035). There was no significant difference in risk of wound infection for absorbable vs non-absorbable sutures in
women who did not undergo fascia closure.
Conclusion: The combination of subcutaneous fascia closure and skin closure with an absorbable suture may be
associated with an increased risk of reported wound infection after caesarean section.
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Background
Caesarean section is one of the most commonly per-
formed surgical procedures for women worldwide [1].
Rates of caesarean section vary widely globally, from as
low as 5% in predominantly low-income countries, to as
high as 47% in some high-income countries [2]. While
the World Health Organization (WHO) has recom-
mended a caesarean section rate no higher than 15% [3],
it is acknowledged that the “optimal” caesarean section
rate is not known [4, 5]. Among developed health care
settings, approximately 30% of women will birth via cae-
sarean section [6–9].
Women who birth by caesarean section have a 5 to 20
times increased risk of peri-partum infective complica-
tions, compared with women who birth vaginally [10–12].
Surgical site infections have been reported to occur in up
to 12% of procedures [10, 13, 14]. Additionally, wound
complications such as haematoma, seroma and dehiscence
can complicate recovery after caesarean section [15], all of
which may have a negative impact on postnatal maternal
health and wellbeing, a woman’s ability to care for her in-
fant, and her overall experience of the postnatal period.
Operative techniques vary widely between surgeons
[16, 17]. While skin closure with staples compared with
a subcuticular suture has been associated with an in-
creased risk of postoperative wound complication in one
systematic review which included observational data,
[18] this difference was not observed when considering
data from randomised trials only [19]. It is not known
which (if any) type of skin suture is preferable [19, 20].
A systematic review of 10 trials of closure or non-clos-
ure of the subcutaneous fascia found a significant re-
duction in wound seroma but not in wound
haematoma or infection [21]. The choice of suture ma-
terial for skin closure and the decision to close the sub-
cutaneous fascia can potentially influence the risk of
wound infection and complications. There is currently
insufficient evidence to guide practitioners as to the op-
timal technique to adopt.
We performed a 2 × 2 factorial randomised trial com-
paring the effects of absorbable versus non-absorbable
skin suture, and closure or non-closure of the subcuta-
neous fascia, on wound infection and complication rates.
Methods
Design
Single centre 2 × 2 factorial randomised trial, allocated 1:1.
Ethics
The trial was reviewed and approved by the Human Re-
search Ethics Committee of the Women’s and Children’s
Hospital, North Adelaide (Approval number: 1539/ 12).
Participants
Eligible women were identified and recruited from a
single tertiary metropolitan maternity hospital in Adelaide,
South Australia. Women were identified in antenatal
clinic, given a trial information sheet and counselled by a
researcher, after which written informed consent was ob-
tained. Women who were undergoing a caesarean section
via a transverse suprapubic incision were eligible for inclu-
sion. Women with a known lethal fetal anomaly or where
the procedure was planned via a midline skin incision
were excluded.
Randomisation, allocation concealment, and blinding
Randomisation occurred at the time of decision to per-
form a caesarean section, by taking the next sequentially
numbered treatment pack containing the skin suture
material and indication of whether or not to perform
subcutaneous fascia closure. The computer-generated
randomisation schedule used balanced variable blocks,
and was prepared by an investigator not involved with
recruitment or clinical care of the participants. The ran-
domisation schedule was stratified according to the type
of caesarean section (emergency vs elective) and mater-
nal BMI at hospital booking visit (BMI ≤ 25.0 kg/m2 ver-
sus > 25.0 kg/m2). Treatment packs were assembled
according to the prepared schedule by a researcher not
involved with recruitment or clinical care and were
opaque and externally identical. Each treatment pack
contained a sterile pack of suture material (3/0 absorb-
able or 3/0 non-absorbable) and a card documenting
closure or non-closure of the subcutaneous fascia. The
treatment pack was opened by the scrub nurse after de-
livery of the baby. Instructions were relayed to the oper-
ating surgeon, and the suture material opened onto the
operating tray. The operating surgeon and participants
were unblinded to treatment assignment after opening
of the pack. Participant follow up and outcome data col-
lection were performed by investigators not involved in
the primary procedure and who were not aware of treat-
ment allocation. Data analysis was performed following
a statistical analysis plan finalised prior to analyses being
conducted.
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Intervention
The two interventions were:
 Skin closure: subcuticular closure of the skin with a
3/0 absorbable (Caprosyn™) or non-absorbable
(Prolene™) synthetic monofilament suture material
 Fascia closure: closure or non-closure of
subcutaneous fascia, performed with 2/0 Vicryl®
suture
Participants were randomised to each of the two inter-
ventions into one of 4 possible groups:
 Group 1 - non-absorbable skin suture and non-
closure of the subcutaneous fascia;
 Group 2 - absorbable skin suture and non-closure of
the subcutaneous fascia;
 Group 3 - non-absorbable skin suture and closure of
the subcutaneous fascia; and
 Group 4 - absorbable skin suture and closure of the
subcutaneous fascia.
Participant follow-up
Wound complications were identified by asking women
to complete a questionnaire by telephone. Additionally,
hospital case-notes were reviewed at 30 days postpartum,
to identify any diagnosis or signs or symptoms of wound
complications, readmission to hospital, or presentation
to the emergency department.
Outcome
The primary outcomes were:
1. Wound infection reported in first 30 days after
operation defined in accordance with CDC
definition of superficial incisional surgical site
infection [22], including evidence of purulent
discharge; isolation of organisms following tissue or
fluid culture; any of localised pain or tenderness,
swelling, or redness; or the prescription of
antimicrobial therapy.
2. Wound haematoma or seroma formation, defined
as a collection of blood or serous fluid beneath the
skin, diagnosed clinically or by ultrasound
assessment, in first 30 days after operation [23].
Secondary outcomes included, emergency presentation
to health care for wound management, need for surgical
intervention including drainage or debridement in the-
atre or outpatient setting; need for hospital readmission
for wound complications in first 30 days after operation
(both self-report and case note review), and pain score
day three post operative.
Statistical analysis
Allowing for additive treatment effect with the two
interventions in a factorial study design, a sample size of
1230 participants was determined on the basis of 80%
power to detect a relative reduction of 40% in the inci-
dence of wound infection (from 12% [24] to 7%), with
two-sided alpha of 0.05, and allowing for 5% loss to fol-
low up.
Analyses were performed on an intention to treat
basis, according to treatment group allocated at random-
isation, and followed the Statistical Analysis Plan. Ana-
lyses were performed using log binomial regression
models for binary outcomes, and linear regression
models for continuous outcomes. In the case of out-
comes where the number of events was too small for the
planned analysis to be performed, a Fisher’s Exact test
was performed to test the hypothesis of no association
between treatment group and outcome. An interaction
term (suture type x fascia method) was included to test
for synergistic effects (whether effect of suture type dif-
fered according to fascia method; whether effect of fascia
closure differed according to suture type). Separate effect
estimates were therefore derived for each treatment
effect by level of the other treatment and are presented
as RR (absorbable versus non-absorbable suture, and
fascia closure versus non-closure) and 95% CI for binary
outcomes, and differences in means (absorbable – non-
absorbable, and fascia closure – nonclosure) and 95% CI
for continuous outcomes. Both unadjusted and adjusted
analyses were performed, with adjusted models including
stratification variables (elective versus emergency caesar-
ean section, BMI category ≤ 25 kg/m2 versus > 25 kg/
m2), and baseline variables prespecified as potential
confounders (maternal age, smoking status, diabetes,
and previous caesarean section). All analyses were
performed in Stata v16 (StataCorp, College Station,
Texas, USA).
The methodology and reporting of this trial adhered
to CONSORT guidelines [25].
Results
Participants
Participant flow through the trial is shown in Fig. 1, with
women randomised between April 2008 and July 2011,
at a metropolitan maternity unit, The Women’s and
Children’s Hospital, North Adelaide, South Australia.
The trial was ceased prior to achieving the estimated
sample size due to difficulties in maintaining recruitment.
Overall, 851 eligible women were randomised to one
of four groups: Group 1–216 women; Group 2–212
women; Group 3–212 women; and Group 4–211
women. Two women were excluded from the final ana-
lysis, one who was lost to follow up (randomised to
Group 1) and one who did not undergo a caesarean
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birth (randomised to Group 2), leaving 849 women for
whom primary outcome data was available.
Baseline demographic characteristics of women were
comparable between treatment groups (Table 1). The
mean age of participants was 31.48 years (SD 5.62 years),
with mean early pregnancy BMI 28.60 kg/m2 (SD 7.36
kg/m2). The majority of women underwent an elective
caesarean section (701 women [82.57%]), at 38.50 weeks
(SD 1.85 weeks) gestation. Most women were in their
second or subsequent ongoing pregnancy (656 women
[77.27%]), with a previous caesarean birth (562 women
[66.20%]).
Wound infection and complication outcomes
Wound infection and complication outcomes by group
are presented in Table 2. The overall wound infection
Fig. 1 Participant flow through the Closure randomised trial





















Maternal age (years; mean (SD)) 31.26 (5.73) 31.56 (5.32) 31.16 (5.81) 31.93 (5.62) 31.48 (5.62)
BMI (kg/m2) Median (IQR) 28.29 (7.37) 28.84 (7.60) 28.75 (7.33) 28.54 (7.18) 28.60 (7.36)
BMI category (kg/m2) N (%)
- BMI ≤ 25.0 86 (40.00) 79 (37.44) 81 (38.21) 78 (36.97) 324 (38.16)
- BMI >25.0 129 (60.00) 132 (62.56) 131 (61.79) 133 (63.03) 525 (61.84)
Caesarean section type N (%)
- elective 177 (82.33) 175 (82.94) 175 (82.55) 174 (82.46) 701 (82.57)
- emergency 38 (17.67) 36 (17.06) 37 (17.45) 37 (17.54) 148 (17.43)
Gestational age at delivery Mean (SD) 38.34 (2.02) 38.48 (2.12) 38.50 (1.85) 38.70 (1.31) 38.50 (1.85)
Ethnicity N(%)
- Caucasian 155 (72.09) 162 (76.78) 157 (74.06) 167 (79.15) 641 (75.50)
- Other 60 (27.91) 49 (23.22) 55 (25.94) 44 (20.85) 208 (24.50)
Parity N (%)
- 0 48 (22.33) 49 (23.22) 53 (25.00) 43 (20.38) 193 (22.73)
- 1 or more 167 (77.67) 162 (76.78) 159 (75.00) 168 (79.62) 656 (77.27)
Smoker N (%) 40 (18.60) 41 (19.43) 42 (19.81) 34 (16.11) 157 (18.49)
Singleton pregnancy N(%): 207 (96.28) 202 (95.73) 206 (97.17) 202 (95.73) 817 (96.23)
Previous Caesarean section N(%) 146 (67.91) 136 (64.45) 136 (64.15) 144 (68.25) 562 (66.20)
Previous non-caesarean laparotomy N(%) 6 (2.79) 5 (2.37) 6 (2.83) 6 (2.84) 23 (2.71)
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rate was lower than expected, with 66 of 849 women
(7.77%) reporting a postoperative wound infection in the
30 days postpartum (Table 2).
Women who underwent fascia closure and skin clos-
ure with a non-absorbable suture (Group 3) had the
lowest rate of postoperative wound infection (10 women
[4.72%]), while women who underwent fascia closure
and skin closure with an absorbable suture had the high-
est rate of postoperative wound infection (Group 4) (22
women [10.43%]) (Table 2). In women who did not have
fascia closure, rates of wound infection were similar
between those who had skin closure with an absorbable
suture (Group 2) (17 women (7.91%)) and those who
had skin closure with a non-absorbable suture (Group 1)
(17 women (8.06%); see Table 2).
The occurrence of wound haematoma and seroma
were very low, with only 4 women (0.47%) in the whole
cohort having this complication. Two of these women
(0.95%) were in Group 2 (fascia non-closure and absorb-
able skin suture), with a further woman each in Group 1
(0.47%) (fascia non-closure and non-absorbable skin su-
ture) and Group 4 (0.47%) (fascia closure and absorbable
skin suture) (Table 2). Only 5 women (0.59%) required
reoperation, and 3 women (0.35%) readmission for
wound complications in the 30 days following operation
(Table 2).
Effect estimates of different closure techniques
Effect estimates of different closure techniques are pre-
sented in Table 3. Due to the interaction term, estimates
of treatment effects were derived separately for each
level of the other treatment, that is:
 The effect of absorbable sutures vs non-absorbable
skin suture was estimated in participants who had
fascia closure, and in participants who did not have
fascia closure; and
 The effect of fascia closure was estimated in
participants who had absorbable vs non-absorbable
skin sutures.
Among women who underwent fascia closure and had
skin closure with an absorbable suture (Group 4), there
was a statistically significant increased risk of developing
a wound infection in the first 30 days following oper-
ation, compared with women who underwent fascia
closure and then had skin closure with a non-absorbable
suture (Group 3) (adjusted relative risk 2.17; 95% CI
1.05, 4.45; p = 0.035) (Table 3). Among women who did
not have fascia closure, there were no statistically signifi-
cant differences in the risk of wound infection among
women who underwent skin closure with absorbable
suture (Group 2), compared with women who under-
went skin closure with non-absorbable suture (Group 1)
(adjusted relative risk 1.01; 95% CI 0.53, 1.91; p = 0.984)
(Table 3).
Similarly, among women who underwent skin closure
with absorbable suture, there was no statistically significant
difference in risk of wound infection in women who under-
went fascia closure (Group 4), compared with women who
did not have fascia closure (Group 2) (adjusted relative risk
1.27; 95% CI 0.70, 2.31; p = 0.437) (Table 3). In women who
had skin closure with non-absorbable suture, there was very
weak evidence of a lower risk of wound infection for those
who had fascia closure (Group 3), compared with women
who did not have fascia closure (Group 1), although the dif-
ference was not statistically significant (adjusted relative risk
0.59; 95% CI 0.28, 1.25; p = 0.169) (Table 3).
With regards to the outcome of wound haematoma or
seroma, there were too few events to perform the
planned analysis. Fisher’s Exact test showed no evidence
of an association between treatment group and risk of
haematoma or seroma.
While there was a statistically significant effect of
wound closure technique on risk of re-operation (Fish-
er’s exact test, p = 0.013), there were too few events to
perform modelling on this outcome (Table 3). Four
women who required re-operation were in the fascia
closure and absorbable skin suture (Group 4) (1.90%)
and 1 woman in the fascia non-closure and absorbable
skin suture group (Group 1) (0.47%) (Table 2).



















Wound infection N(%) 17 (7.91) 17 (8.06) 10 (4.72) 22 (10.43) 66 (7.77)
Haematoma/Seroma N(%) 1 (0.47) 2 (0.95) 0 (0.00) 4 (1.90) 7 (0.82)
Reoperation N(%) 0 (0.00) 1 (0.47) 0 (0.00) 4 (1.90) 5 (0.59)
Readmission N(%) 0 (0.00) 0 (0.00) 1 (0.47) 2 (0.95) 3 (0.35)
Emergency presentation
for wound management N(%)
14 (6.51) 8 (3.79) 9 (4.25) 17 (8.06) 48 (5.65)
Pain score at day 3 Mean (SD) 2.87 (1.91) 3.02 (1.99) 3.09 (2.06) 2.85 (2.12)
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There was no statistically significant treatment effect of
any of the wound closure techniques on readmission rates,
or emergency presentation for wound review (Table 3).
Discussion
Main findings
Overall, we found no strong evidence of effect for either
the use of absorbable versus non-absorbable skin suture,
or closure versus non-closure if the subcutaneous fascia.
There was very weak evidence to suggest that the com-
bination of subcutaneous fascia closure and skin closure
with a non-absorbable skin suture was associated with a
reduced risk of infection, but this finding should be
interpreted with caution as no statistical adjustment has
been made for multiple comparisons. Given low event
rates and likelihood that any effect of the interventions
is of small magnitude, future trials would have to be very
large to properly investigate differences while accounting
for any possible effect modification.
Comparison with published literature
We have shown that there is some weak evidence to
suggest that the combined intervention of subcutane-
ous fascia closure and skin suturing with absorbable
monofilament suture (Caprosyn™), is associated with an
increased risk of postoperative wound infection, in
comparison with subcutaneous fascia closure and skin
suturing with non-absorbable monofilament suture
(Prolene™). While previous studies have shown no
statistically significant difference in wound infection
rates when comparing the use of absorbable versus
non-absorbable skin sutures [26–28], the combination
of subcutaneous fascia closure (or non-closure) with
different skin sutures has not been considered.









Wound Infection 0.117* 0.119*
Non-absorbable versus absorbable suture with fascia
non-closure
1.02 (0.53, 1.94) 0.954 1.01 (0.53, 1.91) 0.984
Non-absorbable versus absorbable suture with fascia
closure
2.21 (1.07, 4.55) 0.031 2.17 (1.05, 4.45) 0.035
Fascia non-closure versus closure with non-absorbable
suture
0.60 (0.28, 1.27) 0.181 0.59 (0.28, 1.25) 0.169
Fascia non-closure versus closure with absorbable suture 1.29 (0.71, 2.37) 0.402 1.27 (0.70, 2.31) 0.437
Haematoma/Seromaa
- Fishers Exact Test 0.574
Re-Operationa
- Fishers Exact Test 0.013
Readmissiona
- Fishers Exact Test 0.246
Emergency Presentation 0.045* 0.046*
- Absorbable suture and fascia non-closure 0.58 (0.25, 1.36) 0.211 0.58 (0.25, 1.35) 0.205
- Absorbable suture and fascia closure 1.90 (0.87, 4.16) 0.110 1.87 (0.85, 4.08) 0.118
- Fascia closure and non-absorbable suture 0.65 (0.29, 1.47) 0.304 0.64 (0.29, 1.45) 0.288
- Fascia closure and absorbable suture 2.12 (0.94, 4.82) 0.071 2.07 (0.92, 4.69) 0.080
Day 3 Pain Score 0.223* 0.221*
- Absorbable suture and fascia non-closure 0.15 (−0.29, 0.59) 0.505 0.15 (−0.29, 0.59) 0.514
- Absorbable suture and fascia closure −0.24 (−0.69, 0.21) 0.291 −0.24 (− 0.69, 0.20) 0.282
- Fascia closure and non-absorbable suture 0.22 (−0.22, 0.67) 0.327 0.23 (−0.21, 0.68) 0.309
- Fascia closure and absorbable suture −0.17 (− 0.61, 0.27) 0.459 − 0.16 (− 0.60, 0.28) 0.477
* Denotes p value for test of interaction (is the effect of one treatment affected by the other treatment)
a Too few events to allow modelling. Fisher’s Exact test was performed to test for any association between group (suture type x fascia closure) and outcome
b These outcomes were assessed at two time points; planned analyses were log binomial regression model (for binary categorisation) and ordinal logistic
regression (for original 3 categories), with GEE to account for repeated measures. Due to extremely small numbers in ‘dissatisfied’ category, neither of these
modelling approaches was possible. Instead, Fisher’s Exact test has been performed separately at each time point
c Log Poisson regression with robust variance has been used for the adjusted model instead of log binomial regression due to convergence issues
d Adjusted analyses included stratification variables (emergency vs elective caesarean section, BMI category (≤25 vs >25), age, smoking status, diabetes and
previous caesarean section
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One possible reason for our findings is that the burden
of absorbable suture material is related to the increased
relative risk of wound infection, among women who
underwent subcutaneous fascia closure and skin closure
with absorbable suture. Both the suture used for subcuta-
neous fascia closure (Vicryl®), and the suture used for skin
closure (Caprosyn™) are absorbable. Vicryl® is a poly-
filament, braided absorbable synthetic suture, which is
completely absorbed within 56–70 days [29]. Caprosyn™ is
a short-term absorbable monofilament suture, which is
completely absorbed within 56 days [30]. Whenever a
foreign body such as a suture, is placed within tissue, it
induces an inflammatory reaction [31]. Absorption of
absorbable suture material Vicryl® can cause tissue reac-
tions that consist of free fluid, that may facilitate bacterial
growth, [31] and the congregation of macrophages and
fibroblasts, lymphocytes and plasma cells, which gradually
reduce in number and concentration postoperatively [32,
33]. Optimal wound healing requires an appropriate
amount of tissue inflammation [34], however it is possible
that the additive burden of concurrent tissue inflamma-
tory responses is sufficient to result in excessive inflamma-
tion, decreased efficiency of removal of contaminating
micro-organisms [34], and an increased risk of clinical
wound infection.
Potentially at odds with this theory is the observation that
women who had skin closure with a non-absorbable suture
and did not have closure of the subcutaneous fascia had
rates of infection similar to women with fascia closure and
absorbable skin sutures. This may be due to an additive ef-
fect of two sources of an inflammatory response to foreign
material and the possibility that closure of the subcutane-
ous fascia is somewhat protective from post-operative
wound infection, particularly in a population of women
where more than 60% have a BMI of 25 kg/m2 or more.
It is generally acknowledged that routine closure of
the subcutaneous fascia is not recommended, having not
been shown to reduce the risk of wound infection (NICE
guidelines 2015) [35]. Closure of fascia among women
with more than two centimetres depth of subcutaneous
fat to reduce wound infection, possibly secondary to
elimination of wound dead space has been considered
with mixed findings [36, 37].
Maternal overweight and obesity is an increasingly
common issue in current obstetric practice, with ap-
proximately 50% of women across developed countries
entering pregnancy overweight or obese [6, 38–40].
Overweight and obesity represents a significant inde-
pendent risk factor for wound infection [41, 42], and at
a population level, considering the use of non-
absorbable, rather than absorbable skin sutures among
women who require closure of the subcutaneous fascia
may result in significant reductions in wound infection,
and warrants further consideration.
Strengths and limitations
A major strength of our study is the large sample size of
851 women randomised. To our knowledge, this repre-
sents the largest randomised trial of wound closure tech-
niques published to date. Although we did not attain our
pre-specified sample size of 1230 women due to slow
recruitment, our results represent a significant addition
to the published literature on the effect of different
wound and subcutaneous fascia closure techniques on
wound infection and complication rates. However, this
study remains underpowered for the primary outcome,
with a lower than anticipated rate of both wound infec-
tion and associated complications rates, and the possibil-
ity of synergistic effects between the two interventions, a
much larger sample size would be required to properly
study these techniques.
Our finding of a statistically significant increased rela-
tive risk of wound infection among women who had
fascia closure and skin closure with an absorbable suture
is supported by the direction of the effect estimate
towards a lower relative risk of wound infection among
women who underwent fascia closure and skin closure
with a non-absorbable suture, despite this effect estimate
not being statistically significant. Additionally, while
there were too few events to allow for effect estimates to
be calculated with regards to our secondary outcome of
wound reoperation, four out of five women who under-
went a wound reoperation had undergone fascia closure
and skin closure with an absorbable suture, further sup-
porting our findings.
Conclusions
Use of non-absorbable skin suture should be considered
at caesarean section, as should consideration of closure
of the subcutaneous fascia. These findings may be of
significant clinical relevance in light of increasing rates
of maternal overweight and obesity. Further research
should consider fascia closure or non-closure in women
with high BMI and the appropriate skin suture material
in this population.
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